Celadon Pharmaceuticals PLC

LSE:CEL UK Drug Manufacturers - Specialty & Generic

Market Cap

$112.25K

GBX922.53 Million GBX

Market Cap Rank

#48012 Global

#1124 in UK

Share Price

GBX13.40

Change (1 day)

+0.00%

52-Week Range

GBX4.50 - GBX15.00

All Time High

GBX320.00

Celadon Pharmaceuticals PLC - Asset Resilience Ratio

Latest as of June 2024: -3.21%

Celadon Pharmaceuticals PLC (CEL) has an Asset Resilience Ratio of -3.21% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

GBX-272.00K

Cash + Short-term Investments

Total Assets

GBX8.46 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Celadon Pharmaceuticals PLC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Celadon Pharmaceuticals PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX-272.00K	-3.21%
Total Liquid Assets	GBX-272.00K	-3.21%

Asset Resilience Insights

Limited Liquidity: Celadon Pharmaceuticals PLC maintains only -3.21% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.